- 全部删除
您的购物车当前为空
Ralaniten triacetate (EPI-506) 是 Ralaniten 的前体,是一种具有口服活性的雄激素受体 N 端结构域 (AR-NTD) 抑制剂,具有抗癌活性,可用于研究前列腺癌和乳腺癌。

Ralaniten triacetate (EPI-506) 是 Ralaniten 的前体,是一种具有口服活性的雄激素受体 N 端结构域 (AR-NTD) 抑制剂,具有抗癌活性,可用于研究前列腺癌和乳腺癌。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 1,650 | In stock | |
| 5 mg | ¥ 4,130 | In stock | |
| 10 mg | ¥ 5,880 | In stock | |
| 25 mg | ¥ 8,750 | In stock | |
| 50 mg | ¥ 11,800 | In stock | |
| 100 mg | ¥ 15,900 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 4,750 | In stock |
Ralaniten triacetate 相关产品
| 产品描述 | Ralaniten triacetate (EPI-506), a precursor of Ralaniten, is a first-of-its-kind, orally active androgen receptor N-terminal structural domain (AR-NTD) inhibitor with anticancer activity and can be used to study prostate and breast cancer. |
| 体外活性 | Ralaniten triacetate (EPI-506) 靶向雄激素受体(AR)的 N 末端结构域的高特异性小分子,可与 AR 上的新靶点 N 端结构域 (NTD) 结合,常用于转移性去势抵抗性前列腺癌 (mCRPC)研究[2]。 |
| 别名 | EPI-506 |
| 分子量 | 521.00 |
| 分子式 | C27H33ClO8 |
| CAS No. | 1637573-04-6 |
| Smiles | CC(=O)OC[C@H](COc1ccc(cc1)C(C)(C)c1ccc(OC[C@@H](CCl)OC(C)=O)cc1)OC(C)=O |
| 密度 | 1.188 g/cm3 (Predicted) |
| 存储 | Pure form: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 80 mg/mL (153.55 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容